Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 22, 2006
Study of 1,558 patients was designed to retrospectively compare one-year clinical outcomes in real-world practice
-
Oct 18, 2006
"In Q3 we were able to achieve results near the high end of our previously announced preliminary sales and earnings ranges," said Jim Tobin, President and CEO
-
Oct 18, 2006
Results to include new data on next-generation TAXUS® Liberte™ Stent System
-
Oct 16, 2006
MAPS trial demonstrates Company's commitment to understanding the efficacy and durability of endovascular therapies for the treatment of brain aneurysms
-
Oct 16, 2006PROMUS stent to complement Company's market-leading TAXUS® stent systems
Boston Scientific Corporation (NYSE: BSX) announced today that the PROMUS™ Everolimus-Eluting Coronary Stent System has received CE Mark...
-
Oct 12, 2006
Victory supports previous court decisions related to the suit Medtronic filed against Guidant in August 2003
-
Oct 4, 2006
A live webcast and replay of the October 18 conference call will be available
-
Oct 2, 2006FDA approval makes remote monitoring available by more than 150,000 additional patients
FDA approval makes remote monitoring available by more than 150,000 additional patients
-
Sep 29, 2006Gobierno de Puerto Rico aprueba el Sistema Precision, que brinda a los médicos una nueva opción de tratamiento para dolor agudo y crónico
Gobierno de Puerto Rico aprueba el Sistema Precision, que brinda a los médicos una nueva opción de tratamiento para dolor agudo y crónico
-
Sep 28, 2006
Plans for changes consistent with HRS guidelines includes Company's commitment to the development of independent, industry-wide oversight to facilitate consistent communications, surveillance and product performance reporting practices